New eye drug shows promise for diabetic vision loss
NCT ID NCT05681884
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called faricimab in 179 people with non-proliferative diabetic retinopathy, a condition where diabetes damages blood vessels in the eye. The goal was to see if the drug could improve blood flow in the retina over 48 weeks. Participants received either monthly faricimab injections or observation only.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Austin Retina Associates
Austin, Texas, 78705, United States
-
California Retina Consultants
Bakersfield, California, 93309, United States
-
Charleston Neuroscience Institute
Ladson, South Carolina, 29456, United States
-
Florida Retina Institute
Orlando, Florida, 32806, United States
-
Long Island Vitreoretinal Consultants
Westbury, New York, 11590, United States
-
Mississippi Retina Associates
Jackson, Mississippi, 39202, United States
-
North Carolina Retina Associates
Wake Forest, North Carolina, 27587, United States
-
Palmetto Retina Center
West Columbia, South Carolina, 29169, United States
-
Retina Consultants of Minnesota St. Louis Park
Saint Louis Park, Minnesota, 55416, United States
-
Retina Consultants of Texas
Beaumont, Texas, 77707, United States
-
Retina Consultants of Texas
Bellaire, Texas, 77401, United States
-
Retina Consultants of Texas
Katy, Texas, 77494, United States
-
Retina Consultants of Texas
San Antonio, Texas, 78240, United States
-
Retina Consultants of Texas
The Woodlands, Texas, 77384, United States
-
Retina Group of Florida
Sarasota, Florida, 34233, United States
-
Retinal Consultants Medical Group
Modesto, California, 95356, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye drug aims to stop diabetic vision loss
- New study aims to catch diabetic eye disease before it steals sight
- Could eye drops replace needles for diabetic eye swelling?
- Could your genes predict blindness from diabetes?
- Common heart drug may shield eyes of type 1 diabetes patients
- New drug ANXV shows promise for common eye diseases in early trial